Autologous Human Schwann Cell
20220447
Phase 1 mab active
Quick answer
Autologous Human Schwann Cell for Peripheral Nerve Injury is a Phase 1 program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Peripheral Nerve Injury
- Phase
- Phase 1
- Modality
- mab
- Status
- active